Literature DB >> 1716739

In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator.

A E Trezise1, M Buchwald.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). The principal manifestations of CF include increased concentration of Cl- in exocrine gland secretions, pancreatic insufficiency, chronic lung disease, intestinal blockage and malabsorption of fat, and male and female infertility. Insight into the function of CFTR can be gained by correlating its cell-specific expression with the physiology of those cells and with CF pathology. Determination of CFTR messenger RNA in rat tissues by in situ hybridization shows that it is specifically expressed in the ductal cells of the pancreas and the salivary glands. In the intestine, decreasing gradients of expression of the CFTR gene are observed on both the crypt-villus and the proximal-distal axes. This expression is consistent with CFTR being responsible for bidirectional Cl- transport, secretion in the intestinal crypts and reabsorption in the silivary gland ducts, and suggests that in these tissues CFTR functions as a regulated Cl- channel. In the lung, a broad band of hybridization includes the mucosa and submucosa of the bronchi and bronchioles. In the testis, CFTR expression is regulated during the cycle of the seminiferous epithelium. Postmeiotic expression is maximal in the round spermatids of stages VII and VIII, suggesting that CFTR plays a critical role in spermatogenesis and that deficiency of this function contributes to CF male infertility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716739     DOI: 10.1038/353434a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Intestinal ion transport and the pathophysiology of diarrhea.

Authors:  Michael Field
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

Authors:  C R Scriver; T M Fujiwara
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

3.  Complementation of null CF mice with a human CFTR YAC transgene.

Authors:  A L Manson; A E Trezise; L J MacVinish; K D Kasschau; N Birchall; V Episkopou; G Vassaux; M J Evans; W H Colledge; A W Cuthbert; C Huxley
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

4.  Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine.

Authors:  Robert L Jakab; Anne M Collaco; Nadia A Ameen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

5.  Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease.

Authors:  B R Grubb; W K O'Neal; L E Ostrowski; S M Kreda; B Button; R C Boucher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

6.  Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis.

Authors:  Frederick W Woodley; Rodrigo S Machado; Don Hayes; Carlo Di Lorenzo; Ajay Kaul; Beth Skaggs; Karen McCoy; Alpa Patel; Hayat Mousa
Journal:  Dig Dis Sci       Date:  2013-11-28       Impact factor: 3.199

7.  Guanylin and functional coupling proteins in the human salivary glands and gland tumors : expression, cellular localization, and target membrane domains.

Authors:  Hasan Kulaksiz; Elisabeth Rehberg; Wolfgang Stremmel; Yalcin Cetin
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Authors:  Antonius Bronckers; Lida Kalogeraki; Huub J N Jorna; Martina Wilke; Theodore J Bervoets; Donacian M Lyaruu; Behrouz Zandieh-Doulabi; Pamela Denbesten; Hugo de Jonge
Journal:  Bone       Date:  2009-12-30       Impact factor: 4.398

9.  Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.

Authors:  T Markert; A B Vaandrager; S Gambaryan; D Pöhler; C Häusler; U Walter; H R De Jonge; T Jarchau; S M Lohmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Glucose tolerance in patients with cystic fibrosis: five year prospective study.

Authors:  S Lanng; A Hansen; B Thorsteinsson; J Nerup; C Koch
Journal:  BMJ       Date:  1995-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.